HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor

Condition:   Haemophilic Pseudotumour Intervention:   Drug: Emicizumab Sponsors:   Indiana Hemophilia &Thrombosis  Center, Inc.;   Genentech, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials